I know family is important to most people, but I beg to differ. In my situation, my parents think that their children don't love them if they don't inform them on what they're doing.
My relationship with my parents is average. I feel if I ever get married, it would be private and I won't alarm...
Virco BVBA has announced that their HIV resistance testing product, virco®TYPE HIV-1, has achieved CE-Marking approval. virco®TYPE HIV-1 is the only bioinformatic diagnostic device of its kind to carry CE-Marking in the HIV market. The CE-Marking indicates that virco®TYPE HIV-1 is a medical...
AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) announced that the U.S. Food and Drug Administration (FDA) has approved NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) capsules, as the first treatment for pseudobulbar affect. NUEDEXTA is indicated for the treatment of pseudobulbar...
Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) has approved VIVITROL® (naltrexone for extended-release injectable suspension) for the prevention of relapse to opioid dependence, following opioid detoxification. VIVITROL is now the first and only...
Matrix Laboratories Recieves Tentative FDA Approval To Provide Generic ARV Under PEPFAR Pharmaceutical company Mylan announced on Tuesday that its "subsidiary Matrix Laboratories Ltd. has received tentative government approval for atazanavir sulfate capsules, an AIDS treatment that will be...
Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of IPR Pharmaceutical's Crestor ® tablets 5 mg, 10...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced that Caldolor® (ibuprofen) Injection is gaining momentum and being approved for use in a growing number of medical facilities across the country. Several key U.S. hospitals, including Orlando Regional Medical Center, St. Elizabeth...
Roche Molecular Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection...
Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence...
More...
National health organizations applauded the U.S. House Energy and Commerce Health Subcommittee for their favorable vote on legislation to improve the diagnosis, treatment and prevention of the leading killers of American women -- heart disease, stroke and other cardiovascular diseases...
The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval in Hungary to commence a Phase IIa clinical trial with LytixarTM (LTX-109) treatment of skin infections caused by Gram positive bacteria. According to Lytix Biopharma CEO Gunnar Sælid, "We are delighted to...
Takeda Pharmaceutical Company Limited ("Takeda") announced that an additional indication for "NESINA®" (generic name: Alogliptin), combination therapy with thiazolidinediones for type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare. NESINA, a dipeptidyl...
Adult stem cell leader Neostem, Inc. (NYSE Amex: NBS) has been awarded a $700,000 military grant from the U.S. Army's Medical Research and Materiel Command to study adult stem cell applications in the healing of trauma wounds. The award opens new opportunities for the company's patented VSEL...
American Frozen Food Institute (AFFI) President and CEO Kraig R. Naasz issued the following statement applauding the House Education and Labor Committee for approving the Improving Nutrition for America's Children Act. "This legislation reauthorizing federal childhood nutrition programs is...
HRA Pharma announced that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive...
HRA Pharma announced that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive...
HRA Pharma announced that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive...
HRA Pharma announced that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive...